Better surgical techniques, chemotherapy and biological therapy have improved survival in patients with colorectal cancer (CRC), most markedly in younger patients. About half of patients over 70 years receive dose reductions or early treatment discontinuation of the planned adjuvant or first-line treatment due to side effects. | The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer A randomized trial GERICO